Catalyst Wire Dossier Catalyst Wire Dossier

LAMA

long-acting muscarinic antagonist
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LAMA, covering 2015-09-10 to 2022-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment

See pricing